{
    "2021-03-30": [
        [
            {
                "time": "",
                "original_text": "中泰证券给予欧普康视买入评级，业绩延续高增长，向眼视光综合服务商迈进",
                "features": {
                    "keywords": [
                        "欧普康视",
                        "买入评级",
                        "高增长",
                        "眼视光综合服务商"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "欧普康视去年净利4.3亿增4成 总市值达560亿元",
                "features": {
                    "keywords": [
                        "欧普康视",
                        "净利",
                        "增长",
                        "总市值"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "东吴证券--欧普康视2020年年报点评：业绩好于我们预期，持续夯实未来增长基础【公司研究】",
                "features": {
                    "keywords": [
                        "欧普康视",
                        "年报点评",
                        "业绩超预期",
                        "增长基础"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "欧普康视(300595.SZ)2020年度净利润升41.2%至4.33亿元拟10送3.5转0.5派0.93元",
                "features": {
                    "keywords": [
                        "欧普康视",
                        "净利润",
                        "增长",
                        "分红方案"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：业绩催化白马股反弹 医疗服务领涨",
                "features": {
                    "keywords": [
                        "医药生物",
                        "周报",
                        "业绩催化",
                        "白马股反弹",
                        "医疗服务"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业跨市场周报：重视医药板块配置 春意渐浓花正开",
                "features": {
                    "keywords": [
                        "医药生物",
                        "跨市场周报",
                        "板块配置",
                        "春意渐浓"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}